BackMedicenna Therapeutics Overview

Medicenna Therapeutics Total Liabilities

Medicenna Therapeutics's total liabilities is $4.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$4.31M
50.19% YoYΔ $-4.34M vs prior year quarter

Peer average

Loading

Medicenna Therapeutics Total Liabilities History

Loading

Medicenna Therapeutics vs. peers: Total Liabilities Comparison

Loading

Medicenna Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Medicenna Therapeutics (MDNA) FAQ

As of the most recent data (September 2023), MDNA shows a total liabilities of $4.3M. That compares with $8.6M in the prior-year period — down 50.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MDNA's total liabilities is now $4.3M (was $8.6M) — a 50.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Medicenna Therapeutics is outperforming or lagging.

Tracking MDNA's total liabilities over time shows whether Medicenna Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $4.3M That compares with $8.6M in the prior-year period — down 50.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Medicenna Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $4.3M) with ownership activity and broader fundamentals.

Medicenna Therapeutics's total liabilities is $4.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.